Journal profile

Journal of translational medicine

Publisher: BioMed Central
ISSN1479-5876 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.99
Citation rate 11.46 21,707 total citations
h5-index 116 h5 depth signal
Cited share 94.6% 1,987 of 2,100
Total citations 21,707 Citation footprint
Metric signal 11.77 External metric anchor
Self-citation 2.0% 432 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 5,205
United States 1,115
Italy 673
Germany 372
United Kingdom 246

Citing Fields of Research

Immunology 1,906
Oncology 1,143
Cancer & Development 1,110
Noncoding RNA 802
Genetics & Genomics 584

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 10,862 Articles tracked across the journal lifetime
Indexed publication set 2,100 1,987 cited publications
Last 12 months 1,909 159.1 publications/month
Open access share 100.0% 1,909 OA publications in the last year
Leading citing country China 5,205 citing publications
Leading citing field Immunology 1,906 citing publications
Latest tracked publication 13 November 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v5, 2007-
PubMed
v1n1,2003-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Immunology Cancer & Development Oncology Noncoding RNA Cancer, Autophagy & Apoptosis Inflammatory Bowel Diseases & Infections

Issuing & Sponsoring Bodies

Contributor
BioMed Central Ltd

Broad Categories

Medicine Immunology Cancer, Autophagy & Apoptosis Noncoding RNA Genetics & Genomics Inflammatory Bowel Diseases & Infections Cancer & Development

MeSH Descriptors

Biomedical Research Clinical Medicine

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

07
Danni Cen, Qian Li, Ying Xu et al.
Background.: Chemoresistance in triple-negative breast cancer (TNBC) remains a critical driver of relapse and metastasis. Current explanatory models—EMT reversibility, the absence of upstream CSC drivers, TGF-β pleiotropy, and fragmented...
09
Nixi Xu, Yuanwu Cao, Zhiyang Zhang et al.
Background: CDKN2A -associated senescence-like changes and degeneration-related changes frequently coexist in the nucleus pulposus (NP), but their cellular and transcriptional features may not fully overlap. This study investigated donor...

Bibliographical & Catalog Notes

Title from home page (viewed Sept. 22, 2003).

Latest issue consulted: 1:5 (19 Sept. 2003) (viewed Sept. 22, 2003).

Articles added consecutively to current annual v.

Mode of access: World Wide Web.